14-31084758-GT-GTT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001128126.3(AP4S1):​c.306+4182dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,613,258 control chromosomes in the GnomAD database, including 7 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0010 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 4 hom. )

Consequence

AP4S1
NM_001128126.3 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.422

Publications

1 publications found
Variant links:
Genes affected
AP4S1 (HGNC:575): (adaptor related protein complex 4 subunit sigma 1) This gene encodes a member of the adaptor complexes small subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is the small subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Mutations in this gene are associated with spastic quadriplegic cerebral palsy-6. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Dec 2011]
AP4S1 Gene-Disease associations (from GenCC):
  • AP-4 deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 52
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • AP4-related intellectual disability and spastic paraplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-31084758-G-GT is Benign according to our data. Variant chr14-31084758-G-GT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00116 (1695/1461220) while in subpopulation MID AF = 0.0101 (58/5764). AF 95% confidence interval is 0.00799. There are 4 homozygotes in GnomAdExome4. There are 875 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128126.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP4S1
NM_001128126.3
MANE Select
c.306+4182dupT
intron
N/ANP_001121598.1
AP4S1
NM_007077.5
c.367-3dupT
splice_acceptor intron
N/ANP_009008.2
AP4S1
NM_001254727.2
c.*39-3dupT
splice_acceptor intron
N/ANP_001241656.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP4S1
ENST00000542754.7
TSL:1 MANE Select
c.306+4174_306+4175insT
intron
N/AENSP00000438170.2
AP4S1
ENST00000334725.8
TSL:1
c.*39-11_*39-10insT
intron
N/AENSP00000334484.4
AP4S1
ENST00000216366.9
TSL:1
c.*13-11_*13-10insT
intron
N/AENSP00000216366.5

Frequencies

GnomAD3 genomes
AF:
0.00105
AC:
160
AN:
151922
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00197
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00208
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00138
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00127
AC:
319
AN:
250256
AF XY:
0.00138
show subpopulations
Gnomad AFR exome
AF:
0.000189
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00157
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00116
AC:
1695
AN:
1461220
Hom.:
4
Cov.:
31
AF XY:
0.00120
AC XY:
875
AN XY:
726920
show subpopulations
African (AFR)
AF:
0.000418
AC:
14
AN:
33462
American (AMR)
AF:
0.00152
AC:
68
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00322
AC:
84
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.00111
AC:
96
AN:
86244
European-Finnish (FIN)
AF:
0.000319
AC:
17
AN:
53364
Middle Eastern (MID)
AF:
0.0101
AC:
58
AN:
5764
European-Non Finnish (NFE)
AF:
0.00113
AC:
1256
AN:
1111552
Other (OTH)
AF:
0.00169
AC:
102
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00105
AC:
159
AN:
152038
Hom.:
3
Cov.:
32
AF XY:
0.00101
AC XY:
75
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41456
American (AMR)
AF:
0.00197
AC:
30
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4806
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10598
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00138
AC:
94
AN:
67974
Other (OTH)
AF:
0.00143
AC:
3
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00131
Hom.:
0
Bravo
AF:
0.00118

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 06, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Spastic paraplegia Benign:1
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary spastic paraplegia Benign:1
Aug 20, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766477779; hg19: chr14-31553964; COSMIC: COSV99364439; COSMIC: COSV99364439; API